Transdermal nicotine effects on attention

Psychopharmacology

Volumn 140, Issue 2, 1998, Pages 135-141

  Levin, Edward D ^a   Conners, C Keith ^a   Silva, Donna ^a   Hinton, Sean C ^a   Meck, Warren H ^a   March, John ^a   Rose, Jed E ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Attention; Nicotine skin patches; Transdermal nicotine

Indexed keywords

NICOTINE;

ADULT; ALZHEIMER DISEASE; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NICOTINE;

EID: 0031766318     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050750     Document Type: Article

References (43)

1. Arendash GW, Sengstock GJ, Sanberg PR, Kem WR (1995) Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Res 674:252-259
2. Barkley R (1990) Attention deficit hyperactivity disorder: a handbook for diagnosis and treatment. Guilford, New York
3. Barkley RA, Murphy K, Kwasnik D (1996) Psychological adjustment and adaptive impairments in young adults with ADHD. J Attent Disord 1:41-54
4. Bates T, Mangan G, Stough C, Corballis P (1995) Smoking, processing speed and attention in a choice reaction time task. Psychopharmacology 120:209-212
5. Henchierif M, Lovette ME, Fowler KW, Arrington S, Reeves L, Caldwell WS, Lippiello PM (1996) RJR-2403: a nicotinic agonist with CNS selectivity. I. In vitro characterization. J Pharmacol Exp Ther 279:1413-1421
6. Benowitz NL (1993) Nicotine replacement therapy: what has been accomplished can we do better? Drugs 45:157-170
7. Benowitz NL, Porchet H, Jacob IP (1989) Nicotine dependence and tolerance in man: pharmacokinetic and pharmacodynamic investigations. In: Nordberg A, Fuxe K, Holmstedt B, Sundwall A (eds) Progress in Brain Research. Elsevier, New York, pp 279-287
8. Bryson HM, Benfield P (1997) Donepezil. Drugs Aging 10:234-239
9. Church R, Miller KD, Meck WH, Gibbon J (1991) Symmetrical and asymmetrical sources of variance in temporal generalization. Anim Learn Behav 19:207-214
10. Coger RW, Moe KL, Serafetinides EA (1996) Attention deficit disorder in adults and nicotine dependence: psychobiological factors in resistance to recovery? J Psychoact Drugs 28:229-240
11. Conners CK (1994) The continuous performance test (CPT): use as a diagnostic tool and measure of treatment outcome. Annual Convention of the American Psychological Association. Los Angeles, Calif
12. Conners CK (1995) The continuous performance test. Multi-Health Systems, Toronto
13. Conners CK, March JS, Fiore C, Butcher T (1994) Information processing deficits in ADHD: effect of stimulus rate and methylphenidate. Annual Meeting of the American College of Neuropsychopharmacology
14. Conners CK, Levin ED, Sparrow E, Hinton S, Ernhardt D, Meck WH, Rose JE, March J (1996) Nicotine and attention in adult ADHD. Psychopharmacol Bull 32:67-73
15. Epstein JN, Conners CK, Sitarenios G, Erhardt D (1998) Use of the continuous performance test with adults with attention deficit/hyperactivity disorder (ADHD). Clin Neuropsychol (in press)
16. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
17. Hoffman BB, Lefkowitz RJ (1996) Catecholamines. sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Gilman AG, Limbird LE (eds) Goodman & Gilman's the pharmacological basis of therapeutics McGraw Hill, New York, pp 199-263
18. Hughes JR (1989) Dependence potential and abuse liability of nicotine replacement therapies. Biomed Pharmacother 43:11-17
19. Jones GMM, Sahakian BJ, Levy R, Warburton DM, Gray JA (1992) Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108:485-494
20. Koelega HS (1993) Stimulant drugs and vigilance performance: a review. Psychopharmacology 111:1-16
21. Levin E, Wilson W, Rose J, McEvoy J (1996a) Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15:429-436
22. Levin ED, Conners CK, Sparrow E, Hinton S, Meck W, Rose JE, Ernhardt D, March J (1996b) Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology 123:55-63
23. Lippiello PM, Benchierif M, Gray JA, Peters S, Grigoryan G, Hodges H, Collins AC (1996) RJR-2403: a nicotinic agonist with CNS selectivity II. In vivo characterization. J Pharmacol Exp Ther 279:1422-1429
24. McNair DM, Lorr M, Droppleman LF (1981) EdITS manual for the profile of mood states. Educational and Industrial Testing Service, San Diego
25. Meck WH, Church RM (1987) Cholinergic modulation of the content of temporal memory. Behav Neurosci 101:457-464
26. Menzaghi F, Whelan KT, Risbrough VB, Rao TS, Lloyd GK (1997) Interactions between a novel cholinergic ion channel agonist. SIB-1765F and L-DOPA in the reserpine model of Parkinson's disease in rats. J Pharmacol Exp Ther 280:393-401
27. Newhouse P, Potter A, Corwin J (1996) Acute administration of the cholinergic channel activator ABT-418 improves learning in Alzheimer's disease. Society for Research on Nicotine and Tobacco. Poster A39, Washington, D.C.
28. NIMH (1985) CGI (clinical global impression) scale. Psychopharmacol Bull 21:839-843
29. Peeke SC, Peeke HVS (1984) Attention, memory, and cigarette smoking. Psychopharmacology 84:205-216
30. Pickworth WB, Bunker EB, Henningfield JE (1994) Transdermal nicotine: reduction of smoking with minimal abuse liability. Psychopharmacology 115:9-14
31. Pomerleau CS (1997) Co-factors for smoking and evolutionary psychobiology. Addiction 92:397-408
32. Prendergast MA, Terry AV, Jackson WJ, Marsh KC, Decker MW, Arneric SP, Buccafusco JJ (1997) Improvement in accuracy of delayed recall in aged and non-aged, mature monkeys after intramuscular or transdermal administration of the CNS nicotinic receptor agonist ABT-418. Psychopharmacology 130:276-284
33. Rakitin BC, Gibbon J, Penney TB, Malapani C, Hinton SC, Meck WH (1998) Scalar expectancy theory and peak-interval timing in humans. Anim Behav Proc (in press)
34. Sacaan AI, Reid RT, Santori EM, Adams P, Correa LD, Mahaffy LS, Bleicher L, Cosford NDP, Stauderman KA, McDonald LA, Rao TS, Lloyd GK (1997) Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist. J Pharmacol Exp Ther 280:373-383
35. Sahakian BJ, Coull JT (1993) Tetrahydroaminoacridine (THA) in Alzheimer's disease: an assessment of attentional and mnemonic function using CANTAB. Acta Neurol Scand Suppl 149:29-35
36. Sahakian BJ, Jones GMM (1991) The effects of nicotine on attention, information processing, and working memory in patients with dementia of the Alzheimer type. In: Adlkofer F, Thruau K (eds) Effects of nicotine on biological systems. Birkhäuser Basel, pp 623-230
37. Warburton DM, Arnall C (1994) Improvements in performance without nicotine withdrawal. Psychopharmacology 115: 539-542
38. Warburton DM, Rusted JM, Fowler J (1992) A comparison of the attentional and consolidation hypotheses for the facilitation of memory by nicotine. Psychopharmacology 108:443-447
39. Wesnes K, Warburton DM (1983) Smoking, nicotine and human performance. Pharmacol Ther 21:189-208
40. Wesnes K, Warburton DM (1984a) The effects of cigarettes of varying yield on rapid information processing performance. Psychopharmacology 82:338-342
41. Wesnes K, Warburton DM (1984b) Effects of scopolamine and nicotine on human rapid information information processing performance. Psychopharmacology 82:147-150
42. Williams JBW (1988) A structured interview guide for the Hamilton depression rating scale. Arch Gen Psychiatry 45:742-747
43. Wonnacott S, Irons J, Rapier C, Thorne B, Lunt GG (1989) Presynaptic modulation of transmitter release by nicotinic receptors. In: Nordberg A, Fuxe K, Holmstedt B, Sundwall A (eds) Progress in Brain Research. Elsevier, New York, pp 157-163